NCT04770194View on ClinicalTrials.gov

Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SP-8008

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

January 23, 2020

Study Completion Date

January 23, 2020

Conditions
Acute Coronary SyndromeStroke
Interventions
DRUG

SP-8008 Prototype Capsule A

Oral

DRUG

SP-8008 Prototype Capsule B

Oral

DRUG

Placebo

Oral

Trial Locations (1)

NG11 6JS

Quotient Sciences, Nottingham

All Listed Sponsors
lead

Shin Poong Pharmaceutical Co. Ltd.

INDUSTRY

NCT04770194 - Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SP-8008 | Biotech Hunter | Biotech Hunter